QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
Free Trial

Compare Stocks

→ Your eBook: Mastering Earnings Announcements Trading (From StockEarnings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IMV Inc. stock logo
IMV
IMV
$0.66
$0.48
▼
$12.70
$9.63M0.95233,607 shs44,800 shs
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
C$13.60
C$7.13
▼
C$590.00
C$317.06MN/A8,002 shs921 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IMV Inc. stock logo
IMV
IMV
0.00%0.00%0.00%0.00%+49.55%
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IMV Inc. stock logo
IMV
IMV
N/AN/AN/AN/AN/AN/AN/AN/A
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IMV Inc. stock logo
IMV
IMV
2.00
HoldN/AN/A
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IMV Inc. stock logo
IMV
IMV
$330K0.00N/AN/A($0.69) per share0.00
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
C$39.91M0.00N/A3.94C$6.07 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IMV Inc. stock logo
IMV
IMV
-$37.99M-$4.59N/AN/AN/A-11,547.42%-12,695.41%-104.84%N/A
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A-C$63.06N/AN/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IMV Inc. stock logo
IMV
IMV
N/AN/AN/AN/AN/A
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IMV Inc. stock logo
IMV
IMV
N/A
2.93
2.93
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
37.47
4.06
3.66

Ownership

Institutional Ownership

CompanyInstitutional Ownership
IMV Inc. stock logo
IMV
IMV
15.37%
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A

Insider Ownership

CompanyInsider Ownership
IMV Inc. stock logo
IMV
IMV
0.33%
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
IMV Inc. stock logo
IMV
IMV
9711.71 million11.67 millionOptionable
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
48723.31 millionN/ANot Optionable

PLI, SPL, TLX, and IMV Headlines

SourceHeadline
Panetta Institute for Public PolicyPanetta Institute for Public Policy
scu.edu - March 31 at 4:05 PM
2024 Breakthrough Prizes in Life Sciences2024 Breakthrough Prizes in Life Sciences
the-scientist.com - October 11 at 4:23 AM
TMC Life Sciences Bhd (TMCN)TMC Life Sciences Bhd (TMCN)
investing.com - July 24 at 12:48 PM
Life Sciences Learning CommunityLife Sciences Learning Community
slu.edu - June 13 at 7:57 PM
Chicago Life Sciences SummitChicago Life Sciences Summit
bisnow.com - April 21 at 4:16 PM
College of Liberal Arts & SciencesCollege of Liberal Arts & Sciences
alfred.edu - April 10 at 2:50 PM
Lab­vi­va nets $20M Se­ries A to ease life sci­ence pro­cure­ment processLab­vi­va nets $20M Se­ries A to ease life sci­ence pro­cure­ment process
endpts.com - March 27 at 9:38 AM
Trends that will shape the life sciences industry in 2023 and beyondTrends that will shape the life sciences industry in 2023 and beyond
hindustantimes.com - February 24 at 6:14 PM
Pharma sector gets first tranche of payment under under PLI schemePharma sector gets first tranche of payment under under PLI scheme
moneycontrol.com - February 24 at 6:14 PM
Arithmos appoints Maurizio Giraudo as Managing Director of the new Life Sciences Business Consulting UnitArithmos appoints Maurizio Giraudo as Managing Director of the new Life Sciences Business Consulting Unit
finance.yahoo.com - February 21 at 12:31 PM
WEF, Telangana joins hands to start thematic centre on healthcare and life sciencesWEF, Telangana joins hands to start thematic centre on healthcare and life sciences
health.economictimes.indiatimes.com - January 18 at 6:06 PM
Working on PLI schemes for more sectors: Piyush GoyalWorking on PLI schemes for more sectors: Piyush Goyal
retail.economictimes.indiatimes.com - September 24 at 9:00 PM
TSX:CVE (CENOVUS ENERGY INC.)TSX:CVE (CENOVUS ENERGY INC.)
fool.ca - July 31 at 12:45 AM

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

IMV logo

IMV

NASDAQ:IMV
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
ProMetic Life Sciences logo

ProMetic Life Sciences

TSE:PLI
Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.